28448 Federal Register / Vol. 83, No. 118 / Tuesday, June 19, 2018 / Notices 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993— Medical Technology 

Enterprise Consortium 

Notice is hereby given that, on May 3, 

2018, pursuant to Section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), Medical Technology 

Enterprise Consortium (‘‘MTEC’’) has 

filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, Adventist Health System/ 

Sunbelt, Inc. dba Florida Hospital, 

Orlando, FL; AegisCN LLC, Durham, 

NC; AmpliPhi Biosciences Corporation, 

San Diego, CA; Auckland UniServices 

Limited, Auckland, NEW ZEALAND; 

AxoGen Corporation, Alachua, FL; 

Axonova Medical, LLC, Philadelphia, 

PA; Blood Systems, Inc. dba Blood 

Systems Research Institute, Scottsdale, 

AZ; Blumio, Inc., San Francisco, CA; 

Board of Trustees of the Leland Stanford 

Junior University, Palo Alto, CA; 

Cellphire, Inc., Rockville, MD; Clinical 

Research Management, Inc. dba ICON 

Government and Public Health 

Solutions (ICON GPHS), Hinckley, OH; 

Cohen Veterans Bioscience, Inc., 

Cambridge, MA; Deloitte Consulting 

LLP, McLean, VA; Design Interactive, 

Inc., Orlando, FL; Disarm Therapeutics, 

Inc., Cambridge, MA; Dynport Vaccine 

Company LLC, Frederick, MD; 

Engineering and Computer Simulations, 

Inc., Orlando, FL; EyeSonix LLC, Long 

Beach, CA; Fibralign Corp., Union City, 

CA; FlexDex, Inc., Brighton, MI; FloTBI, 

Cleveland, OH; Fortuna Fix, London, 

UK; Imbed Biosciences, Fitchburg, WI; 

Kitware, Inc., Clifton Park, NY; 

LayerBio, Inc., Arlington, MA; LifeLens 

Technologies, LLC, Warrington, PA; 

Massachusetts Eye and Ear Infirmary, 

Boston, MA; MVK Pharmaceuticals, 

LLC, Indianapolis, IN; National Trauma 

Institute dba Coalition for National 

Trauma Research, San Antonio, TX; 

New York University School of 

Medicine, New York, NY; Noveome 

Biotherapeutics, Inc., Pittsburgh, PA; 

Pendar Technologies LLC, Cambridge, 

MA; Pluristem LTD, Haifa, ISRAEL; 

Quantum Applied Science and 

Research, Inc., San Diego, CA; RegenFix, 

LLC, Toledo, OH; Renerva, LLC, 

Pittsburgh, PA; ReNetX Bio, Inc., New 

Haven, CT; SAVIR GmbH, Berlin, 

GERMANY; Scion NeuroStim, LLC, 

Raleigh, NC; Selfit Medical Ltd., Ramat 

Ha’sharon, ISRAEL; SOL–DEL 

MEDICAL LTD., KFAR SABA, ISRAEL; 

Southern Research Institute, 

Birmingham, AL; SRI International, 

Menlo Park, CA; TerumoBCT, Inc., 

Lakewood, CO; The Children’s Hospital 

Corporation dba Boston Children’s 

Hospital, Boston, MA; The Informatics 

Applications Group, Inc., Reston, VA; 

The Methodist Hospital Research 

Institute dba Houston Methodist 

Research Institute, Houston, TX; 

University of California, San Diego, San 

Diego, CA; University of California, San 

Francisco, San Francisco, CA; 

University of Kentucky Research 

Foundation, Lexington, KY; URO– 

RESEARCH, LLC, Houston, TX; West 

Virginia University Research 

Corporation, Morgantown, WV; 

WESTAT, Inc., Rockville, MD; and Yale 

University, New Haven, CT, have been 

added as parties to this venture. 

Also, Aequor, Inc., Oceanside, CA; 

Brainpaths LLC, Las Vegas, NV; Combat 

Wounded Veteran Challenge, Inc., Saint 

Petersburg, FL; Infinite Arthroscopy, 

Inc., Cleveland Heights, OH; Institute 

for Applied Neurosciences, Charleston, 

SC; Kestrel Corporation, Albuquerque, 

NM; LifeLink Foundation, Inc., Tampa, 

FL; Maryland Development Center, 

Baltimore, MD; Nerves Incorporated, 

Dallas, TX; Neuroplast BV, Maastricht, 

THE NETHERLANDS; Northwestern 

University, Evanston, IL; NovaHep AB, 

Gothenburg, SWEDEN; Pertexa 

Healthcare Technologies, Inc., 

Ridgecrest, CA; The University of 

Cincinnati, Department of Surgery, 

Cincinnati, OH; Trideum BioSciences, 

Frederick, MD; University of South 

Carolina, Columbia, SC; University of 

Utah, Salt Lake City, UT; and 

Vapogenix, Inc., Houston, TX, have 

withdrawn as parties to this venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and MTEC 

intends to file additional written 

notifications disclosing all changes in 

membership. 

On May 9, 2014, MTEC filed its 

original notification pursuant to Section 

6(a) of the Act. The Department of 

Justice published a notice in the Federal 

Register pursuant to Section 6(b) of the 

Act on June 9, 2014 (79 FR 32999). 

The last notification was filed with 

the Department on January 18, 2018. A 

notice was published in the Federal 

Register pursuant to Section 6(b) of the 

Act on March 12, 2018 (83 FR 10751). 

Patricia A. Brink, 

Director of Civil Enforcement, Antitrust 

Division. 

[FR Doc. 2018–13064 Filed 6–18–18; 8:45 am] 

BILLING CODE 4410–11–P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Portable Lights American 

Trade Organization 

Notice is hereby given that, on May 

14, 2018, pursuant to Section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), Portable Lights 

American Trade Organization 

(‘‘PLATO’’) has filed written 

notifications simultaneously with the 

Attorney General and the Federal Trade 

Commission disclosing (1) the name and 

principal place of business of the 

standards development organization 

and (2) the nature and scope of its 

standards development activities. The 

notifications were filed for the purpose 

of invoking the Act’s provisions limiting 

the recovery of antitrust plaintiffs to 

actual damages under specified 

circumstances. 

Pursuant to Section 6(b) of the Act, 

the name and principal place of 

business of the standards development 

organization is: Portable Lights 

American Trade Organization, St. Paul, 

MN. The nature and scope of PLATO’s 

standards development activities are: 

Basic performance requirements for 

hand-held, portable flashlights, 

spotlights and headlamps that provide 

directional lighting. It includes relevant 

definitions, test methods and marking 

requirements in order to establish 

minimum performance for these 

consumer devices. The project will 

consider expanding the scope to include 

portable area lights in addition to 

directional lighting, as well as any 

relevant updates needed for test 

methods. 

Patricia A. Brink, 

Director of Civil Enforcement, Antitrust 

Division. 

[FR Doc. 2018–13059 Filed 6–18–18; 8:45 am] 

BILLING CODE 4410–11–P 


daltland on DSKBBV9HB2PROD with NOTICES